Study reveals how bile acids impact immunotherapy in liver cancer

Immunotherapy is a modern approach to cancer treatment that uses a patient’s own immune system to help fight tumors.

J&J earnings a ‘positive early indicator’ for medtech in Q2: analyst

By the numbers Q2 revenue: $25.5 billion 6.3% increase year-over-year Medtech revenue: $7.79 billion 12.9% increase year-over-year Net income: $5.14 billion 6.9% increase year-over-year Q2

July 20, 2023

Lilly backs OrsoBio’s $60M Series A for PhII trials in obesity and NASH

OrsoBio, a biotech focused on obesity and metabolic disorders, is getting financial support from one of the leading drugmakers in the field as Eli Lilly

November 8, 2023

Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing – Biotech Investments

EQS-News: Partex NV / Key word(s): Agreement Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing 14.03.2024 / 09:00 CET/CEST The issuer

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.